Skip to Content

Notice

Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

ACTION:

Notice of application.

DATES:

Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before June 26, 2017.

ADDRESSES:

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152.

End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (“Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix to subpart R.

In accordance with 21 CFR 1301.33(a), this is notice that on November 22, 2016, Siegfried USA, LLC, 33 Industrial Park Road, Pennsville, New Jersey 08070 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:

Controlled substanceDrug codeSchedule
Gamma Hydroxybutyric Acid2010I
Dihydromorphine9145I
Hydromorphinol9301I
Methylphenidate1724II
Amobarbital2125II
Pentobarbital2270II
Secobarbital2315II
Start Printed Page 19085
Codeine9050II
Oxycodone9143II
Hydromorphone9150II
Hydrocodone9193II
Methadone9250II
Methadone intermediate9254II
Dextropropoxyphene, bulk (non-dosage forms)9273II
Morphine9300II
Oripavine9330II
Thebaine9333II
Opium tincture9630II
Oxymorphone9652II

The company plans to manufacturer the listed controlled substances in bulk for distribution to its customers.

Start Signature

Dated: April 18, 2017.

Louis J. Milione,

Assistant Administrator.

End Signature End Supplemental Information

[FR Doc. 2017-08347 Filed 4-24-17; 8:45 am]

BILLING CODE 4410-09-P